Study on synthesis of ursodeoxycholic acid by reduction of 7-ketolithocholic acid in double aprotic solvents and molecular simulations

Abstract

Ursodeoxycholic acid (UDCA) is not only safer than chenodeoxycholic acid in the treatment of hepatobiliary diseases, but also has a wide range of applications in Acute Kidney Injury and Parkinson’s Disease. The purpose of this experiment is to improve the conversion rate of 7-ketocholic acid (7K-LCA) and the yield of ursodeoxycholic acid in aprotic solvents during electrochemical reduction process. Three aprotic solvents were investigated as electrolytes. 1,3-Dimethyl-2-imidazolidinone (DMI) has a stable five-membered ring structure, and 7K-LCA has undergone two nucleophilic reactions and “Walden” inversion, the 7K-LCK was stereoselectively reduced to UDCA. Hexamethylphosphoramide (HMPA) and 1,3-methyl-3,4,5,6-Tetrahydro-2(1H)-pyrimidinone (DMPU) can be attacked by chloride ions to produce by-products. Molecular orbital theory-based simulations were conducted to study the reducibility of three aprotic solvents [hexamethylphosphoramide (HMPA), 1,3-methyl-3,4,5,6-Tetrahydro-2(1H)-pyrimidinone (DMPU), and 1,3-Dimethyl-2-imidazolidinone (DMI)] in combination with experiments. Choose the best solvent based on the simulation results, the electrolysis reaction can be carried out by applying current and voltage when lithium chloride is used as electrolytes. Calculations using Materials Studio showed that Cu, Pb, Hg–Cu, and Ni exhibited the highest binding energies to the substrate in this system. Using Cu as the electrode when the solvent is a 1:1 mix of DMI and HMPA, the conversion rate of 7-ketocholic acid (could reach 98%, the yield of ursodeoxycholic acid was up to 80%. Under the same conditions, linear voltammetry was performed on the electrochemical workstation to study the electrolysis behavior, and the obtained results were consistent with the experiment.

Keywords

7-Ketolithocholic acid / Ursodeoxycholic acid / Aprotic solvent / Linear sweep voltammetry / Molecular simulation

References

[1] Chen W, Hu D, Liu G. Synthesis of ursodeoxycholic acid from dehydroiso-androsterone 3-acetate. Chem J Chin Univ Chin, 2021, 42: 2782-2788.

[2] Cole EB, Bocarsly A, Bocarsly AB, Cole E (xxxx) Heterocycle catalyzed electrochemical reduction of a carbonyl compound, comprises introducing carbonyl compound into solution of e.g. electrolyte in divided electrochemical cell, varying and separating obtained aldehyde compounds. Liquid Light Inc; Univ Princeton

[3] Hashiba H, Yotsuhashi S, Deguchi M, Yamada Y. Systematic analysis of electrochemical CO₂ reduction with various reaction parameters using combinatorial reactors. ACS Comb Sci, 2016, 18: 203-208.

[4] Hattori M, Mikami K, Sekine T (xxxx) Selective redn. of bile acid having keto gp. at 7-position by reacting bile acid in presence of base using nickel catalyst in normal lower alcohol. Tanabe Co., Tokyo

[5] Huang X, Cao X. Preparation of ursodeoxycholic acid from 7-ketone lithocholic acid by stereoselective electroreduction. Bioresour Bioprocess, 2015, 2: 1-9.

[6] Kekhusroo R. Bharucha; Clarke E.Slemon.(1984) PROCESS FOR THE ELECTROCHEMICAL REDUCTION OF 7- KETOLITHOCHOLIC ACID TO URSODEOXYCHOLIC ACID. United States Patent 4547,271

[7] Khan IA, Saxena AK. Metal-free, mild, nonepimerizing, chemo- and enantio- or diastereoselective N-alkylation of amines by alcohols via oxidation/imine-iminium formation/reductive amination: a pragmatic synthesis of octahydropyrazinopyridoindoles and higher ring analogues. J Org Chem, 2013, 78: 11656-11669.

[8] Kim H, Lee J, Lee SJ, Oh JE, Kim SD, Malpani YR, Hwang YJ, Park BY. Improving the sustainability and safety of ursodeoxycholic acid synthesis in continuous flow process with water. J Ind Eng Chem, 2023, 119: 327-334.

[9] Konig M, Lin S-H, Vaes J, Pant D, Klemm E. Integration of aprotic CO₂ reduction to oxalate at a Pb catalyst into a GDE flow cell configuration. Faraday Discuss, 2021, 230: 360-374.

[10] Kuntyi O, Zozulya G, Shepida M. CO₂ electroreduction in organic aprotic solvents: a mini review. J Chem, 2022, 2022: 1-12.

[11] Lazarus G, Francie J, Roeslani RD, Saldi SRF, Oswari H. Role of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a systematic review and meta-analysis of randomized controlled trials. Ital J Pediatr, 2022, 48: 179.

[12] Li H, Wu B, Wang PDF, Zhang PDX. Achieving efficient and low content Ru-based catalyst for acetylene hydrochlorination based on N,N′-dimethylpropyleneurea. ChemCatChem, 2018, 10(18): 4090-4099.

[13] Liu FL, Cheng YJ, Wu J, Tauschel HD, Duan RD. Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells. Cancer Lett, 2006, 235: 141-146.

[14] Luxenburger A, Clemmens H, Hastings C, Harris LD, Ure EM, Cameron SA, Aasly J, Bandmann O, Weymouth-Wilson A, Furneaux RH, Mortiboys H. 3alpha,7-Dihydroxy-14(13 → 12)abeo-5 beta,12 alpha(H),13 beta(H)-cholan-24-oic acids display neuroprotective properties in common forms of Parkinson’s disease. Biomolecules, 2023, 13: 76.

[15] Mena S, Ribas E, Richart C, Gallardo I, Faraudo J, Shaw SK, Guirado G. Electrochemical tools to disclose the electrochemical reduction mechanism of CO₂ in aprotic solvents and ionic liquids. J Electroanal Chem, 2021, 895.

[16] Qi H, Shen D, Jiang C, Wang H, Chang M. Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP/MPP+-induced Parkinson’s disease. Neurosci Lett, 2021, 741.

[17] Sandipan H, Shmaryahu H. Hydroxylated HMPA enhances both reduction potential and proton donation in SmI₂ reactions. J Org Chem, 2014, 79: 2682-2687.

[18] Santos VN, Lanzoni VP, Szejnfeld J, Shigueoka D, Parise ER. A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid. Braz J Med Biol Res, 2003, 36: 723-729.

[19] Sathe AG, Tuite P, Chen C, Ma Y, Chen W, Cloyd J, Low WC, Steer CJ, Lee B-Y, Zhu X-H, Coles LD. Pharmacokinetics, safety, and tolerability of orally administered ursodeoxycholic acid in patients with Parkinson’s disease—a pilot study. J Clin Pharmacol, 2020, 60: 744-750.

[20] Shen J, Dong D, Wang Z, Wan J, Cao X. Synthesis of ursodeoxycholic acid by electrochemical stereoselective reduction of 7-ketolithocholic acid in aprotic solvents. Sci Rep, 2021, 11: 16273.

[21] Tsugio K, Keisuke G, Toshimasa K. Synthesis of 1,2-bis(trimethylsilyl)benzene derivatives from 1,2-dichlorobenzenes using a hybrid metal Mg/CuCl in the presence of LiCl in 1,3-dimethyl-2-imidazolidinone. J Org Chem, 2013, 78: 3421-3424.

[22] Xiaolei M, Xuejun C. Separation of ursodeoxycholic acid by silylation crystallization. Bioresour Bioprocess, 2014, 1: 1-8.

[23] Yang B-Y, You Z-N, Xue J-T, Pan J, Li C-X, Xu J-H. Clean enzymatic production of ursodeoxycholic acid enabled by a newly identified NADH-dependent 7β-hydroxysteroid dehydrogenase. Mol Catal, 2023, 537.